Navigation Links
Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017
Date:6/18/2013

DUBLIN, June 18, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/4b8vj2/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This is due to surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self-injection devices.

The growth of the injectable drug delivery technologies market is primarily triggered by product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market.


Key Topics Covered:

1 Introduction

1.1 Key Take-Aways

2 Executive Summary

3 Market Overview

4 Global Injectable Drug Delivery Devices Technologies Market

5 Global Injectable Drug Delivery Formulation Technologies Market

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications

7 Geographic Analysis

8 Competitive Landscape

9 Company Profiles

Companies Mentioned

- Alkermes, Inc.
- Antares Pharma, Inc.
- Baxter International, Inc.
- Becton, Dickinson And Company
- Bespak Europe, Ltd.
- Crossject
- Elcam Medical
- Eli Lilly And Company
- Gerresheimer Ag
- Haselmeier Gmbh
- Injex Pharma Gmbh
- Novo Nordisk A/S
- Owen Mumford, Ltd.
- Sanofi
- Schott Ag
- Shl Group
- Terumo Corporation
- Unilife Corporation
- Vetter Pharma-Fertigung Gmbh & Co. Kg
- West Pharmaceutical Services, Inc.
- Ypsomed Holding Ag
- Zogenix, Inc.

For more information visit http://www.researchandmarkets.com/research/4b8vj2/injectable_drug

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
2. Using 3-D printing and injectable molds, bioengineered ears look and act like the real thing
3. Mylan to Acquire Agila to Create Leading Global Injectables Platform
4. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
5. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
6. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
7. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
8. ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets
9. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
10. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
11. Successful human tests for first wirelessly controlled drug-delivery chip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... focused on quality, regulatory and technical consulting, provides a free webinar ... presented on July 13, 2016 at 12pm CT at no charge. , Incomplete ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... partnership that will allow them to produce up ... (HiPSC) from one lot within one week. These ... their time laboriously preparing cells and spend more ... made possible through a proprietary, high-volume manufacturing process ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):